Central African Republic (the)

in page functions
[French]
Central African Republic
Total population (2016) 4,998,478
Birth cohort (2016) 165,453
Surviving Infants (surviving to 1 year per year, 2016) 151,173
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 92/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 130/1000
World Bank Index, IDA (2012) 2.75
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 30

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Central African Republic

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Total $33,423,247 $33,691,747 $32,343,495
Health system strengthening (HSS 1) $3,163,000 $3,163,000 $3,163,000 100%
Immunisation services support (ISS) $1,611,360 $1,879,860 $1,611,360 100%
Injection Safety Devices (NVS) $52,000 $52,000
Injection safety support (INS) $119,651 $119,651 $119,651 100%
IPV (NVS) $363,000 $363,000 $167,340 46%
Meningitis A (NVS) $104,500 $104,500 $103,303 99%
Meningitis A - campaign (NVS) $2,933,000 $2,933,000 $3,106,647 106%
Meningitis A - operational costs (OPC) $2,343,000 $2,343,000 $2,342,943 100%
Penta (NVS) $8,251,257 $8,251,257 $7,781,378 94%
Pneumo (NVS) $11,752,843 $11,752,843 $11,482,485 98%
Rotavirus (NVS) $229,000 $229,000 0%
Vaccine Introduction Grant (VIG) $703,586 $703,586 $564,586 80%
Yellow Fever (NVS) $1,797,050 $1,797,050 $1,900,802 106%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Central African Republic DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 47%
M:F sex ratio at birth (2016) 1.03
Household survey: DTP3 coverage for male (2009) 33.10%
Household survey: DTP3 coverage for female (2009) 31.10%
Household survey: Last DTP3 survey (2009) 32%
% districts achieving > 80% DTP3 coverage (2015) 7%
% districts achieving < 50% DTP3 coverage (2015) 53%
MCV WHO/UNICEF estimates (2015) 49%

Breakdown of support

Non-vaccine support Vaccine support
24% 76%
$7,701,540 $24,541,951

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Central African Republic

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

12 November 2015

Gavi default item

Measles vaccination has saved an estimated 17.1 million lives since 2000

New data released by the World Health Organization (WHO) for the Measles & Rubella Initiative, estimates that 17.1 million lives have been saved since 2000, largely due to increased vaccination coverage against this highly contagious viral disease.

close icon

modal window here